Rizatriptan Benzoate
- Product NDC
- 57237-085
- 11-digit product format
- 572370085
- Labeler code
- 57237
- Product ID
- 57237-085_e693bf18-c909-41c8-bfd5-21cb4458b925
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rizatriptan Benzoate
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA203062
- Marketing category
- ANDA
- Marketing start
- 2013-07-01
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rizatriptan Benzoate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIZATRIPTAN BENZOATE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WR978S7QHH |
| Rxcui | 312837, 312839 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 57237-085-63 | Rizatriptan Benzoate | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | | 10 |
| 57237-085-63 | Rizatriptan Benzoate | 6 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 6 | | 10 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| RIZATRIPTAN BENZOATE | ACTIVE INGREDIENT | WR978S7QHH | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [CITRON PHARMA LLC] | 2 | |
| RIZATRIPTAN | ACTIVE MOIETY | 51086HBW8G | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [CITRON PHARMA LLC] | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [CITRON PHARMA LLC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [CITRON PHARMA LLC] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [CITRON PHARMA LLC] | 2 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [CITRON PHARMA LLC] | 2 | |
| PEPPERMINT | INACTIVE INGREDIENT | V95R5KMY2B | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [CITRON PHARMA LLC] | 2 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [CITRON PHARMA LLC] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [CITRON PHARMA LLC] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 57237-085 | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [RISING PHARMA HOLDINGS, INC.] | 10 | Current NDC, Legacy NDC, 2 package rows | 20240222_2337e102-8df0-4e7f-81d8-5cb86cd48674.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 57237-085-63 | 57237008563 | 3 BLISTER PACK in 1 CARTON (57237-085-63) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 3 blister pack | 2013-07-01 | 0000-00-00 | No | No | Current |